1. What is antiphospholipid syndrome (APS)? Antiphospholipid syndrome (APS) is a systemic autoimmune disorder in which the patient’s immune system makes antibodies (antiphospholipid antibodies [aPL]) ...

1. What is antiphospholipid syndrome (APS)? Antiphospholipid syndrome (APS) is a systemic autoimmune disorder in which the patient’s immune system makes antibodies (antiphospholipid antibodies [aPL]) ...

RAY-121 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Antiphospholipid Syndrome.

Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations ...

The antiphospholipid syndrome associated with hepatic vein thrombosis has usually been of the primary type; that is, the American Rheumatism Association criteria for the diagnosis of systemic ...

Thrombosis in women can be life-threatening during pregnancy and hormone therapy. Learn how to manage the risks effectively.

RAY-121 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Behcet Disease. According to GlobalData, Phase I drugs for Behcet Disease have a 77% phase transition ...

Patients with SLE have a higher prevalence of primary headaches vs those with RA or pSS, but similar percentages were found ...

Background: The HELLP syndrome is a serious complication in pregnancy characterized by haemolysis, elevated liver enzymes and low platelet count occurring in 0.5 to 0.9% of all pregnancies and in ...

A man who suffered a life-changing blood clots around New Year’s Eve last year has spoken the last 12 months, as he looks ahead to 2025 ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. Although Trousseau’s syndrome can be readily recognised if a patient with a previously ...

Sep. 25, 2024 — People with Down syndrome face a higher risk of developing leukemia. Now researchers explain why, by identifying specific changes in blood cells of people with Down ...